Key result
Early measurement of natriuretic peptides within 30 minutes of a post-attack period may help clinicians diagnose supraventricular tachycardia in patients with normal ECGs.
Why the study?
Does early measurement of natriuretic peptides improve the diagnosis of supraventricular tachycardia in patients presenting with palpitations and normal ECG?
Does early measurement of natriuretic peptides improve the diagnosis of supraventricular tachycardia in patients presenting with palpitations and normal ECG?
Answers are grounded in this paper and cite their sources.
Early measurement of natriuretic peptides within 30 minutes of symptom cessation may aid in diagnosing supraventricular tachycardia in patients presenting with normal ECGs.
It is important not to overlook supraventricular tachycardia (SVT) in patients complaining of palpitation or tachycardia-related symptoms but with normal ECG and heart rate in emergency department or outpatient clinics. The severity and presentation of symptoms is highly variable and depends on features including heart rate, duration of tachycardia, underlying heart disease, and individual patient perception. Early measurement of natriuretic peptides in patients presenting with palpitation and/or tachycardia-related symptoms would guide the clinician to rule out tachycardia and/or SVT. High levels of natriuretic peptides within 30 min of postattack period would certainly increase the likelihood of SVT.
No takes yet. Share an insight, caveat, or question.
Ertan Yetkın (2018) conducted a review in Supraventricular tachycardia. Natriuretic peptides measurement was evaluated. Early measurement of natriuretic peptides within 30 minutes of a post-attack period may help clinicians diagnose supraventricular tachycardia in patients with normal ECGs.
Synapse has enriched 10 related papers. Consider them for comparative context: